Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 5/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP14 | P50281 | 1/20 | 0.34 |
| ▸ | ENO1 | P06733 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10710751 | 0.87 | LAP3 (0.32) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| SCHEMBL285956 | 0.85 | CA12 (0.33) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| SCHEMBL17187190 | 0.85 | S1PR2 (0.40) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| SCHEMBL9711407 | 0.83 | TYMS (0.35) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| (Propylamino)Methylenediphosphonic Acid SCHEMBL8817761 | 0.83 | MMP2 (0.50) | MMP2ANPEPERAP2MMP9LAP3 | |
| SCHEMBL8761864 | 0.81 | FDPS (0.48) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| SCHEMBL10613308 | 0.81 | ANPEP (0.34) | MMP2KDM4ETHRBMAPK1HSD17B10 | |
| SCHEMBL18230241 | 0.81 | ANPEP (0.53) | KDM4ECA12CA9ANPEPCA1 | |
| SCHEMBL4368473 | 0.79 | BLM (0.48) | HSD17B10CA12CA9ANPEPCA2 | |
| SCHEMBL11296817 | 0.79 | FOLH1 (0.45) | CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11963761-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2024-04-23 | — | — | US | claimed |
| EP-3204037-B1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | ROCHAL TECH LLC (US) | 2022-12-07 | — | — | EP | claimed |
| EP-3204038-B1 | COMPOSITIONS COMPRISING AMYLASE FOR USE IN THE TREATEMENT OF PRURITUS | ROCHAL TECH LLC (US) | 2022-05-04 | — | — | EP | claimed |
| EP-3847889-A1 | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | Arch Chemicals, Inc. (US) | 2021-07-14 | — | — | EP | claimed |
| US-20200359943-A1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS, INCORPORATED (US) | 2020-11-19 | — | — | US | claimed |
| EP-2787985-B1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2020-07-01 | — | — | EP | claimed |
| US-10688159-B2 | Compositions and kits for treating pruritus and methods of using the same | ROCHAL INDUSTRIES, LLC (US) | 2020-06-23 | — | — | US | claimed |
| US-20200170249-A1 | Biocidal Compositions Comprising Iron Chelators | ARCH CHEMICALS, INC. | 2020-06-04 | — | — | US | claimed |
| EP-1760737-B1 | USE OF AN ELECTROLYTE FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2018-10-31 | — | — | EP | claimed |
| EP-3204037-A1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-08-16 | — | — | EP | claimed |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLP (US) | 2013-06-13 | — | — | US | claimed |
| EP-1755576-A4 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THEIR USE | DERMCARE VET PTY LTD (AU) | 2009-07-08 | — | — | EP | claimed |
| EP-1755576-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THEIR USE | DERMCARE-VET PTY LTD (AU) | 2007-02-28 | — | — | EP | claimed |
| EP-1017427-B1 | USE OF A COMPOSITION COMPRISING A CHELATING AGENT AND AN ANTIMICROBIAL COMPOUND FOR THE TREATMENT OF BIOFILMS | UNIV TEXAS (US) | 2006-04-26 | — | — | EP | claimed |
| EP-1006536-B1 | Electrolytic solution for electrolytic capacitor and electrolytic capacitor using the same | RUBYCON CORP (JP) | 2006-03-15 | — | — | EP | claimed |
| WO-2005097094-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THEIR USE | DERMCARE-VET PTY LTD (AU) | 2005-10-20 | — | — | WO | claimed |
| US-6267979-B1 | PROVIDINY AQUEOUS SYSTEM FORMULATION COMPRISING CHELATING AGENT, AN ANTIMICROBIAL TO CONTROL GROWTH OF MICROORGANISMS | WAKE FOREST UNIVERSITY | 2001-07-31 | — | — | US | claimed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | claimed |
| US-4212518-A | ELECTROCHROMIC CELL | CANON KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-4073700-A | FROM GOLD CYANIDE IN THE PRESENCE OF A CHELATING AGENT | WEISBERG ALFRED M | 1978-02-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200170249-A1 | Biocidal Compositions Comprising Iron Chelators | SLC40A1, TFRC, SLC39A14 | MMP2 1241/4885KDM4E 3199/4885THRB 4425/4885 |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | GCG, BID, DGAT1 | MMP2 235/4885KDM4E 3836/4885THRB 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.